Page last updated: 2024-08-24

triptonide and Neoplasms

triptonide has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L1
Kinghorn, AD; Ren, Y1
Dai, L; He, GN; Song, J1
Cao, Z; Dong, L; Huo, Z; Lv, C; Meng, M; Shi, S; Xiang, S; Xu, X; Yang, B; Yang, L; Zhang, B; Zhang, G; Zhang, P; Zhao, Z; Zhou, Q1

Reviews

2 review(s) available for triptonide and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 162

    Topics: Diterpenes; Epoxy Compounds; Humans; Neoplasms; Phenanthrenes; Triterpenes

2023

Other Studies

2 other study(ies) available for triptonide and Neoplasms

ArticleYear
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Diterpenes; Humans; Neoplasms; Sesquiterpenes; Structure-Activity Relationship; Triterpenes

2020
The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy.
    Cell death and differentiation, 2020, Volume: 27, Issue:8

    Topics: Animals; Apoptosis; Carcinogenesis; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; DNA Repair Enzymes; Female; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Liver X Receptors; Mice, Nude; Mitosis; Models, Biological; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic; Triterpenes; Tumor Suppressor Protein p53

2020